ipa software (GeneGo Inc)
Structured Review

Ipa Software, supplied by GeneGo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ipa+software/ipa+software/pmc05423198-113-18-23
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype"
Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype
Journal: Molecular Oncology
doi: 10.1016/j.molonc.2016.07.006
Figure Legend Snippet: Visual representation of the network generated by Ingenuity Pathway Analysis (IPA). The network included the 5 identified/validated proteins and PPARg with direct and indirect interactions (EZR, LMNA, ENOA, PHB, and RUVBL2 orange stained) with PPARg ...
Techniques Used: Generated, Staining
Related Articles
Generated:Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: The MS‐identified Article Title: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation Article Snippet: A Article Title: HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer Article Snippet: The MS‐identified Software:Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: The MS‐identified Article Title: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation Article Snippet: A Article Title: HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer Article Snippet: The MS‐identified Expressing:Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: The MS‐identified Article Title: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation Article Snippet: A Article Title: HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer Article Snippet: The MS‐identified Western Blot:Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: The MS‐identified Article Title: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation Article Snippet: A Article Title: HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer Article Snippet: The MS‐identified Indirect Immunoperoxidase Assay:Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: The MS‐identified Article Title: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation Article Snippet: A Article Title: HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer Article Snippet: The MS‐identified Staining:Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: Article Title: Proteomic characterization of peroxisome proliferator‐activated receptor‐γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype Article Snippet: The MS‐identified Article Title: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation Article Snippet: A Article Title: HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer Article Snippet: The MS‐identified |

